Wellness Index Report, an independent wellness ratings and education platform, has recognized Nefense as a leader in nasal health innovation in a new Inside the Index feature. The report examines growing consumer interest in nasal health, respiratory hygiene, and drug-free alternatives to traditional care, spotlighting Nefense's hypochlorous acid (HOCl) and xylitol-based products.
The feature reviews emerging research on hypochlorous acid, noting its antimicrobial and anti-inflammatory properties and potential uses across respiratory health and infection control. According to Wellness Index Report, Nefense offers doctor-recommended, ENT-approved, family-friendly HOCl and xylitol-based nasal solutions as a drug-free alternative to over-the-counter sprays. These products are formulated under the direction of Dr. Richard Downs, DDS.
Wellness Index Report, founded by Lindsay O'Neill-O’Keefe, is an independent health and wellness education platform dedicated to helping consumers and medical providers identify evidence-informed wellness solutions through expert review, customer feedback, scientific evaluation, and ongoing performance monitoring. Through its Inside the Index editorial series, the organization highlights companies, practitioners, and technologies shaping the future of wellness and longevity.
The full announcement, including downloadable images and bios, can be viewed here. This recognition underscores the importance of innovative, drug-free approaches to nasal health, particularly as consumers seek alternatives to traditional medications. Nefense's focus on HOCl and xylitol aligns with a broader trend toward natural, evidence-based wellness solutions.
For more information about Wellness Index Report and its ratings, visit their platform. The recognition of Nefense not only validates the company's approach but also highlights the growing demand for safe, effective nasal care products that can be used by the whole family.
